From faulkner.23 at rogers.com  Sun Feb  9 20:16:12 2025
From: faulkner.23 at rogers.com (WILLIAM FAULKNER)
Date: Mon, 10 Feb 2025 01:16:12 +0000 (UTC)
Subject: [Hopespringpcsg] Fw: REMINDER: ClarityDX Prostate - biomarker for
 prostate cancer
In-Reply-To: <003001db7b18$76f59880$64e0c980$@cogeco.ca>
References: <000801db7405$17862f50$46928df0$@cogeco.ca>
 <001b01db7b17$5c88e020$159aa060$@cogeco.ca>
 <003001db7b18$76f59880$64e0c980$@cogeco.ca>
Message-ID: <106036301.5731884.1739150172706@mail.yahoo.com>



Sent from Rogers Yahoo Mail on Android 
 
   
  <!--#yiv7255913075 filtered {}#yiv7255913075 filtered {}#yiv7255913075 filtered {}#yiv7255913075 filtered {}#yiv7255913075 p.yiv7255913075MsoNormal, #yiv7255913075 li.yiv7255913075MsoNormal, #yiv7255913075 div.yiv7255913075MsoNormal {margin:0in;font-size:11.0pt;font-family:"Calibri", sans-serif;}#yiv7255913075 a:link, #yiv7255913075 span.yiv7255913075MsoHyperlink {color:#0563C1;text-decoration:underline;}#yiv7255913075 .yiv7255913075MsoChpDefault {font-size:10.0pt;}#yiv7255913075 filtered {}#yiv7255913075 div.yiv7255913075WordSection1 {}-->
Technological Advances in Prostate Cancer Screening

ClarityDX Prostate uses clinical and blood-based biomarkers to determine a patient’s risk of having clinically significant prostate cancer

ClarityDX Prostate is a decision support tool that accurately predicts clinically significant (aggressive) prostate cancer after an abnormal PSA or a suspicion of prostate cancer.  https://www.nanosticsdx.com/claritydx-prostate/

  

Time: Feb 11, 2025 07:30 PM Eastern Time (US and Canada)

       

Join Zoom Meeting https://us02web.zoom.us/j/82819100419?pwd=TFhVUTZBQTNhZVRRSkE0VU9EM0ordz09

  

Meeting ID: 828 1910 0419; Passcode: 091248

  
  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20250210/26ce9682/attachment.htm>